XIAP, Bir2-Bir3 Domains, His-Tag Recombinant

Catalog #
75002
$350 *
Size: 50 µg
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

Recombinant human XIAP (x-linked inhibitor of apoptosis protein), encompassing amino acids 120-356, corresponding to the Bir2-Bir3 (baculovirus IAP repeat) domains. This construct contains an N-terminal His-tag (6xHis). The protein was affinity purified.

Synonyms
XIAP, IAP-like protein, API3, X-linked IAP, BIRC4, X-linked inhibitor of apoptosis protein, IAP-like protein, ILP1, MIHA, RING-type E3 ubiquitin transferase XIAP, XLP2, Inhibitor of apoptosis protein 3, IAP-3, hIAP3, hIAP-3, Baculoviral IAP repeat-contain
Product Info
Storage and Usage
Citations
Species
Human
Construct
XIAP (Bir2, Bir3) (His-120-356)
Host Species/Expression System
E. coli
Purity

≥80%

Format
Aqueous buffer solution
Formulation

40 mM Tris-HCl, pH 8.0, 110 mM NaCl, 2.2 mM KCl, variable Imidazole, 20% glycerol, 3 mM DTT

MW
28 kDa
Amino Acids
120–356
Genbank #
NM_001167
UniProt #
P98170
Tag(s)
N-terminal His-tag
Background

The XIAP (X-linked inhibitor of apoptosis protein), also known as IAP3 (inhibitor of apoptosis protein 3) and BIRC4 (baculoviral IAP repeat-containing protein 4), is a member of the IAP family of proteins.  XIAP directly regulates caspases and suppresses apoptotic cell death pathways. XIAP has three Bir (baculovirus IAP repeat) domains, involved in binding to caspases. Bir2 inhibits caspase 3 and 7, while Bir3 is involved in caspase 9 inhibition. An increased expression level of XIAP has been observed in many cancer types, such as prostate cancer. Dysfunction of XIAP has been linked to inflammatory bowel disease, cancer, neurodegenerative and autoimmunity disorders.